Danielle Antalffy
Stock Analyst at UBS
(3.80)
# 983
Out of 4,479 analysts
135
Total ratings
50.91%
Success rate
6.84%
Average return
Main Sectors:
35 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMCI Treace Medical Concepts | Downgrades: Neutral | $16 → $6.5 | $6.63 | -1.96% | 4 | May 16, 2024 | |
| SYK Stryker | Maintains: Neutral | $339 → $351 | $334.30 | +5.00% | 4 | May 1, 2024 | |
| BSX Boston Scientific | Maintains: Buy | $74 → $90 | $76.55 | +17.57% | 8 | Apr 25, 2024 | |
| DXCM DexCom | Maintains: Buy | $153 → $163 | $112.49 | +44.90% | 7 | Apr 10, 2024 | |
| ATRC AtriCure | Maintains: Buy | $57 → $58 | $22.39 | +159.04% | 9 | Feb 16, 2024 | |
| INMD InMode | Maintains: Neutral | $24 → $26 | $17.41 | +49.34% | 3 | Feb 14, 2024 | |
| ENOV Enovis | Initiates: Buy | $75 | $44.71 | +67.75% | 1 | Jan 22, 2024 | |
| JNJ Johnson & Johnson | Upgrades: Buy | $180 | $146.03 | +23.26% | 4 | Dec 1, 2023 | |
| INSP Inspire Medical Systems | Maintains: Buy | $405 → $322 | $134.25 | +139.85% | 5 | Sep 6, 2023 | |
| ABT Abbott Laboratories | Assumes: Buy | $117 | $103.20 | +13.37% | 10 | Mar 29, 2023 | |
| BFLY Butterfly Network | Initiates: Neutral | $2.25 | $0.94 | +139.36% | 1 | Mar 29, 2023 | |
| BAX Baxter International | Initiates: Neutral | $43 | $32.85 | +30.90% | 3 | Mar 29, 2023 | |
| ISRG Intuitive Surgical | Initiates: Neutral | $278 | $438.81 | -36.65% | 1 | Mar 29, 2023 | |
| TNDM Tandem Diabetes Care | Initiates: Neutral | $45 | $39.15 | +14.94% | 9 | Mar 29, 2023 | |
| EW Edwards Lifesciences | Initiates: Neutral | $84 | $91.23 | -7.93% | 9 | Mar 29, 2023 | |
| ZBH Zimmer Biomet Holdings | Initiates: Sell | $112 | $106.27 | +5.39% | 3 | Mar 29, 2023 | |
| UTRS Minerva Surgical | Maintains: Outperform | $160 → $140 | $1.48 | +9,359.46% | 3 | May 12, 2022 | |
| RXST RxSight | Maintains: Outperform | $16 → $14 | $57.04 | -75.46% | 1 | May 6, 2022 | |
| PODD Insulet | Maintains: Outperform | $300 → $280 | $197.19 | +42.00% | 8 | May 6, 2022 | |
| OM Outset Medical | Maintains: Outperform | $65 → $55 | $3.77 | +1,358.89% | 2 | May 5, 2022 | |
| AXGN AxoGen | Maintains: Outperform | $12 → $14 | $7.52 | +86.17% | 1 | May 5, 2022 | |
| LNTH Lantheus Holdings | Maintains: Outperform | $75 → $100 | $78.50 | +27.39% | 2 | May 2, 2022 | |
| NPCE NeuroPace | Maintains: Outperform | $15 → $12 | $7.23 | +65.98% | 3 | Mar 11, 2022 | |
| PRCT PROCEPT BioRobotics | Maintains: Outperform | $25 → $30 | $63.16 | -52.50% | 2 | Mar 9, 2022 | |
| AXNX Axonics | Maintains: Outperform | $60 → $65 | $67.45 | -3.63% | 3 | Feb 25, 2022 | |
| VCEL Vericel | Maintains: Outperform | $40 → $45 | $45.07 | -0.16% | 3 | Feb 25, 2022 | |
| NVRO Nevro | Maintains: Outperform | $105 → $85 | $8.35 | +917.96% | 6 | Feb 24, 2022 | |
| NARI Inari Medical | Maintains: Outperform | $85 → $95 | $49.80 | +90.76% | 5 | Feb 24, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Market Perform | $270 → $275 | $229.24 | +19.96% | 1 | Feb 4, 2022 | |
| MDT Medtronic | Maintains: Market Perform | $138 → $115 | $77.37 | +48.64% | 6 | Jan 21, 2022 | |
| ORGO Organogenesis Holdings | Maintains: Outperform | n/a | $2.66 | - | 1 | Nov 10, 2021 | |
| SILK Silk Road Medical | Maintains: Outperform | n/a | $27.02 | - | 1 | Nov 10, 2021 | |
| INGN Inogen | Maintains: Market Perform | n/a | $7.67 | - | 3 | Nov 5, 2021 | |
| SENS Senseonics Holdings | Downgrades: Market Perform | n/a | $0.39 | - | 2 | Apr 1, 2021 | |
| CTSO Cytosorbents | Initiates: Outperform | n/a | $0.82 | - | 1 | Sep 1, 2020 |
Treace Medical Concepts
May 16, 2024
Downgrades: Neutral
Price Target: $16 → $6.5
Current: $6.63
Upside: -1.96%
Stryker
May 1, 2024
Maintains: Neutral
Price Target: $339 → $351
Current: $334.30
Upside: +5.00%
Boston Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $74 → $90
Current: $76.55
Upside: +17.57%
DexCom
Apr 10, 2024
Maintains: Buy
Price Target: $153 → $163
Current: $112.49
Upside: +44.90%
AtriCure
Feb 16, 2024
Maintains: Buy
Price Target: $57 → $58
Current: $22.39
Upside: +159.04%
InMode
Feb 14, 2024
Maintains: Neutral
Price Target: $24 → $26
Current: $17.41
Upside: +49.34%
Enovis
Jan 22, 2024
Initiates: Buy
Price Target: $75
Current: $44.71
Upside: +67.75%
Johnson & Johnson
Dec 1, 2023
Upgrades: Buy
Price Target: $180
Current: $146.03
Upside: +23.26%
Inspire Medical Systems
Sep 6, 2023
Maintains: Buy
Price Target: $405 → $322
Current: $134.25
Upside: +139.85%
Abbott Laboratories
Mar 29, 2023
Assumes: Buy
Price Target: $117
Current: $103.20
Upside: +13.37%
Butterfly Network
Mar 29, 2023
Initiates: Neutral
Price Target: $2.25
Current: $0.94
Upside: +139.36%
Baxter International
Mar 29, 2023
Initiates: Neutral
Price Target: $43
Current: $32.85
Upside: +30.90%
Intuitive Surgical
Mar 29, 2023
Initiates: Neutral
Price Target: $278
Current: $438.81
Upside: -36.65%
Tandem Diabetes Care
Mar 29, 2023
Initiates: Neutral
Price Target: $45
Current: $39.15
Upside: +14.94%
Edwards Lifesciences
Mar 29, 2023
Initiates: Neutral
Price Target: $84
Current: $91.23
Upside: -7.93%
Zimmer Biomet Holdings
Mar 29, 2023
Initiates: Sell
Price Target: $112
Current: $106.27
Upside: +5.39%
Minerva Surgical
May 12, 2022
Maintains: Outperform
Price Target: $160 → $140
Current: $1.48
Upside: +9,359.46%
RxSight
May 6, 2022
Maintains: Outperform
Price Target: $16 → $14
Current: $57.04
Upside: -75.46%
Insulet
May 6, 2022
Maintains: Outperform
Price Target: $300 → $280
Current: $197.19
Upside: +42.00%
Outset Medical
May 5, 2022
Maintains: Outperform
Price Target: $65 → $55
Current: $3.77
Upside: +1,358.89%
AxoGen
May 5, 2022
Maintains: Outperform
Price Target: $12 → $14
Current: $7.52
Upside: +86.17%
Lantheus Holdings
May 2, 2022
Maintains: Outperform
Price Target: $75 → $100
Current: $78.50
Upside: +27.39%
NeuroPace
Mar 11, 2022
Maintains: Outperform
Price Target: $15 → $12
Current: $7.23
Upside: +65.98%
PROCEPT BioRobotics
Mar 9, 2022
Maintains: Outperform
Price Target: $25 → $30
Current: $63.16
Upside: -52.50%
Axonics
Feb 25, 2022
Maintains: Outperform
Price Target: $60 → $65
Current: $67.45
Upside: -3.63%
Vericel
Feb 25, 2022
Maintains: Outperform
Price Target: $40 → $45
Current: $45.07
Upside: -0.16%
Nevro
Feb 24, 2022
Maintains: Outperform
Price Target: $105 → $85
Current: $8.35
Upside: +917.96%
Inari Medical
Feb 24, 2022
Maintains: Outperform
Price Target: $85 → $95
Current: $49.80
Upside: +90.76%
Becton, Dickinson and Company
Feb 4, 2022
Maintains: Market Perform
Price Target: $270 → $275
Current: $229.24
Upside: +19.96%
Medtronic
Jan 21, 2022
Maintains: Market Perform
Price Target: $138 → $115
Current: $77.37
Upside: +48.64%
Organogenesis Holdings
Nov 10, 2021
Maintains: Outperform
Price Target: n/a
Current: $2.66
Upside: -
Silk Road Medical
Nov 10, 2021
Maintains: Outperform
Price Target: n/a
Current: $27.02
Upside: -
Inogen
Nov 5, 2021
Maintains: Market Perform
Price Target: n/a
Current: $7.67
Upside: -
Senseonics Holdings
Apr 1, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $0.39
Upside: -
Cytosorbents
Sep 1, 2020
Initiates: Outperform
Price Target: n/a
Current: $0.82
Upside: -